Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bull Exp Biol Med ; 172(2): 133-136, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34853965

RESUMO

We analyzed changes in activities of enzymes of phases I and II of xenobiotic biotransformation and parameters of NO metabolism in liver microsomes of rats with toxic CCl4-induced hepatitis after a 14-day course of sesquiterpene lactones from Artemisia leucodes (10 mg/kg). It was found that toxic hepatitis was associated with significant inhibition of NADPH-cytochrome c-reductase, benzo(a)pyrene hydroxylase, and NADPH-diaphorase, reduced cytochrome P-450 content, and enhanced induction of nitrate/nitrite reductase with accumulation of NO metabolites in the liver. Administration of sesquiterpene lactones stimulated activity of the studied components of the cytochrome P-450 system and promoted recovery of the NOergic system components; the effects were most pronounced in 7 and 14 days after treatment.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Lactonas/farmacologia , Microssomos Hepáticos/metabolismo , Oxigenases de Função Mista/metabolismo , Óxido Nítrico/metabolismo , Animais , Animais não Endogâmicos , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Doença Hepática Induzida por Substâncias e Drogas/patologia , Sistema Enzimático do Citocromo P-450/metabolismo , Citoproteção/efeitos dos fármacos , Lactonas/uso terapêutico , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/enzimologia , Compostos Fitoquímicos/farmacologia , Ratos , Sesquiterpenos/farmacologia , Sesquiterpenos/uso terapêutico
2.
Bull Exp Biol Med ; 170(1): 24-29, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-33222079

RESUMO

Structural myocardial reorganization and changes in the blood lipid spectrum in rats were studied after administration of a single sublethal dose of doxorubicin (15 mg/kg) alone and in combination with atorvastatin (20 mg/kg/day over 7 days). It was established that doxorubicin induced the development of dyslipidemia in experimental animals (the concentrations of total cholesterol, triglycerides, and VLDL increased by 2.2, 2.0, and 1.96 times, respectively; the atherogenic coefficient increased by 3.4 times by day 7 of the experiment). In animals with experimental anthracycline cardiomyopathy treated with atorvastatin, the concentrations of the main components of the blood lipid spectrum increased less markedly. Atorvastatin alone induces moderate myocardial remodeling in comparison with more pronounced changes in the structural organization of the myocardium in rats treated with doxorubicin alone. Course treatment with atorvastatin under conditions of doxorubicin-induced cardiomyopathy reduced the severity of myocardial remodeling: the decrease in the volume density of cardiomyocytes and the increase in the volume density of the connective tissue were less pronounced in the dynamics of the experiment.


Assuntos
Antibióticos Antineoplásicos/efeitos adversos , Anticolesterolemiantes/farmacologia , Atorvastatina/farmacologia , Cardiomiopatias/tratamento farmacológico , Doxorrubicina/antagonistas & inibidores , Dislipidemias/tratamento farmacológico , Animais , Remodelamento Atrial/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Cardiomiopatias/sangue , Cardiomiopatias/induzido quimicamente , Cardiomiopatias/patologia , Colesterol/sangue , Doxorrubicina/efeitos adversos , Dislipidemias/sangue , Dislipidemias/induzido quimicamente , Dislipidemias/patologia , Feminino , Lipoproteínas VLDL/sangue , Miócitos Cardíacos/efeitos dos fármacos , Miócitos Cardíacos/metabolismo , Miócitos Cardíacos/patologia , Tamanho do Órgão/efeitos dos fármacos , Ratos , Ratos Wistar , Triglicerídeos/sangue
3.
Biomed Khim ; 66(5): 357-371, 2020 Sep.
Artigo em Russo | MEDLINE | ID: mdl-33140729

RESUMO

The manifestation of the side cardiotoxic effect of anthracycline antibiotics limits their use in the treatment of malignant processes in some patients. The review analyzes the main causes of the susceptibility of cardiomyocytes to the damaging effect of anthracyclines, primarily associated with an increase in the processes of free radical oxidation. Currently, research is widely carried out to find ways to reduce anthracycline cardiotoxicity, in particular, the use of cardioprotective agents in the complex treatment of tumors. Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) have been shown to improve the function and metabolism of the cardiovascular system under various pathological impacts, therefore, it is proposed to use them to reduce cardiotoxic complications of chemotherapy. Statins exhibit direct (hypolipidemic) and pleiotropic effects due to the blockade of mevalonic acid synthesis and downward biochemical cascades that determine their cardioprotective properties. The main point of intersection of the pharmacological activity of anthracyclines and statins is the ability of both to regulate the functioning of small GTPase from the Rho family, and their effect in this regard is the opposite. The influence of statins on the modification and membrane dislocation of Rho proteins mediates the indirect antioxidant, anti-inflammatory, endothelioprotective, antiapoptotic effect. The mechanism of statin inhibition of doxorubicin blockade of the DNA-topoisomerase complex, which may be important in preventing cardiotoxic damage during chemotherapy, is discussed. At the same time, it should be noted that the use of statins can be accompanied by adverse side effects: a provocation of increased insulin resistance and glucose tolerance, which often causes them to be canceled in patients with impaired carbohydrate metabolism, so further studies are needed here. The review also analyzes data on the antitumor effect of statins, their ability to sensitize the tumor to treatment with cytostatic drug. It has been shown that the relationship between anthracycline antibiotics and statins is characterized not only by antagonism, but also in some cases by synergism. Despite some adverse effects, statins are one of the most promising cardio- and vasoprotectors for use in anthracycline cardiomyopathy.


Assuntos
Miócitos Cardíacos , Antraciclinas/efeitos adversos , Antibacterianos , Cardiotoxicidade , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/efeitos adversos
4.
Eksp Klin Farmakol ; 75(4): 26-9, 2012.
Artigo em Russo | MEDLINE | ID: mdl-22702108

RESUMO

The introduction of polyprenols isolated from fir (Abies) tree in male rats weighing 170 - 180 g with alcohol-induced hepatitis favored reduction in hepatocyte cytolysis and cholestasis and led to an improvement of the protein- and glycogen-synthesizing function of liver. A clear tendency to normalization of the maintenance of total lipids, triglycerides and phospholipids and the inhibition of lipid peroxidization processes in the damaged organ was observed. The introduction of Abies polyprenols also improved the process of bile secretion and its chemical composition.


Assuntos
Abies/química , Depressores do Sistema Nervoso Central/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Etanol/efeitos adversos , Silimarina/química , Terpenos/farmacologia , Animais , Bile/metabolismo , Depressores do Sistema Nervoso Central/farmacologia , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Etanol/farmacologia , Glicogênio/biossíntese , Hepatócitos/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Biossíntese de Proteínas/efeitos dos fármacos , Ratos , Terpenos/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...